Goldman Sachs Group Inc Opti Nose, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.82 - $1.44 $150,045 - $263,494	182,982 Added 146.34%	308,020 $320,000
Q1 2024 May 15, 2024	BUY	$1.17 - $1.94 $39,733 - $65,882	33,960 Added 37.29%	125,038 $182,000
Q4 2023 Feb 13, 2024	SELL	$1.02 - $1.47 $18,426 - $26,555	-18,065 Reduced 16.55%	91,078 $117,000
Q3 2023 May 14, 2024	BUY	$0.93 - $1.38 $16,800 - $24,929	18,065 Added 19.83%	109,143 $134,000
Q3 2023 Nov 14, 2023	BUY	$0.93 - $1.38 $45,259 - $67,159	48,666 Added 80.47%	109,143 $134,000
Q2 2023 May 14, 2024	SELL	$1.11 - $2.05 $11,102 - $20,504	-10,002 Reduced 14.19%	60,477 $74,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.05 $11,102 - $20,504	-10,002 Reduced 14.19%	60,477 $74,000
Q1 2023 May 14, 2024	BUY	$1.63 - $2.02 $66,492 - $82,401	40,793 Added 137.41%	70,479 $136,000
Q1 2023 May 11, 2023	BUY	$1.63 - $2.02 $66,492 - $82,401	40,793 Added 137.41%	70,479 $136,000
Q4 2022 May 14, 2024	BUY	$1.68 - $3.7 $8,428 - $18,562	5,017 Added 20.34%	29,686 $54,000
Q4 2022 Feb 13, 2023	BUY	$1.68 - $3.7 $8,428 - $18,562	5,017 Added 20.34%	29,686 $54,000
Q3 2022 May 14, 2024	SELL	$3.43 - $4.01 $11,294 - $13,204	-3,293 Reduced 11.78%	24,669 $90,000
Q3 2022 Nov 10, 2022	SELL	$3.43 - $4.01 $11,294 - $13,204	-3,293 Reduced 11.78%	24,669 $90,000
Q2 2022 May 14, 2024	SELL	$1.76 - $3.82 $111,084 - $241,103	-63,116 Reduced 69.3%	27,962 $102,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.82 $111,812 - $242,684	-63,530 Reduced 69.44%	27,962 $102,000
Q1 2022 May 16, 2022	BUY	$1.77 - $2.93 $64,027 - $105,989	36,174 Added 65.39%	91,492 $226,000
Q4 2021 Feb 14, 2022	BUY	$1.55 - $3.1 $38,967 - $77,934	25,140 Added 83.31%	55,318 $90,000
Q3 2021 Nov 10, 2021	BUY	$2.35 - $3.16 $70,918 - $95,362	30,178 New	30,178 $91,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

Mvm Partners, LLC Boston, MA

14.6M
Shares

$7.89 Million
10.4% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

14.4M
Shares

$7.75 Million
0.57% of portfolio
Great Point Partners LLC Greenwich, CT

12.9M
Shares

$6.95 Million
3.98% of portfolio
Stonepine Capital Management, LLC Bend, OR

5.69M
Shares

$3.07 Million
2.41% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

5.6M
Shares

$3.02 Million
0.45% of portfolio

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $45M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account